Cargando…
Subcutaneous integrin inhibitors may provide more treatment options for patients with moderate-to-severe ulcerative colitis
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean Association for the Study of Intestinal Diseases
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667369/ https://www.ncbi.nlm.nih.gov/pubmed/31352773 http://dx.doi.org/10.5217/ir.2019.00070 |
| _version_ | 1783440022170501120 |
|---|---|
| author | Yoon, Hyuk |
| author_facet | Yoon, Hyuk |
| author_sort | Yoon, Hyuk |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6667369 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Korean Association for the Study of Intestinal Diseases |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-66673692019-07-31 Subcutaneous integrin inhibitors may provide more treatment options for patients with moderate-to-severe ulcerative colitis Yoon, Hyuk Intest Res Editorial Korean Association for the Study of Intestinal Diseases 2019-07 2019-07-25 /pmc/articles/PMC6667369/ /pubmed/31352773 http://dx.doi.org/10.5217/ir.2019.00070 Text en © Copyright 2019. Korean Association for the Study of Intestinal Diseases. All rights reserved. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Editorial Yoon, Hyuk Subcutaneous integrin inhibitors may provide more treatment options for patients with moderate-to-severe ulcerative colitis |
| title | Subcutaneous integrin inhibitors may provide more treatment options for patients with moderate-to-severe ulcerative colitis |
| title_full | Subcutaneous integrin inhibitors may provide more treatment options for patients with moderate-to-severe ulcerative colitis |
| title_fullStr | Subcutaneous integrin inhibitors may provide more treatment options for patients with moderate-to-severe ulcerative colitis |
| title_full_unstemmed | Subcutaneous integrin inhibitors may provide more treatment options for patients with moderate-to-severe ulcerative colitis |
| title_short | Subcutaneous integrin inhibitors may provide more treatment options for patients with moderate-to-severe ulcerative colitis |
| title_sort | subcutaneous integrin inhibitors may provide more treatment options for patients with moderate-to-severe ulcerative colitis |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667369/ https://www.ncbi.nlm.nih.gov/pubmed/31352773 http://dx.doi.org/10.5217/ir.2019.00070 |
| work_keys_str_mv | AT yoonhyuk subcutaneousintegrininhibitorsmayprovidemoretreatmentoptionsforpatientswithmoderatetosevereulcerativecolitis |